Paper
0
Cilta-Cel Is Associated with Improved Outcomes and Distinct Cellular Dynamics Compared with Ide-Cel for Relapsed or Refractory Multiple Myeloma
Authors
Nico Gagelmann,Friedrich Stölzel
Roland Fenk,Tobias Holderried,Fabian Mueller,Natalia Tovar,Aina Oliver‐Caldés,Kristin Rathje,Vladan Vučinić,Soraya Kharboutli,Ben-Niklas Bärmann,Francis Ayuk,Uwe Platzbecker,Anca Albici,Natalie Schub,Friederike Schmitz,Cyrus Khandanpour,Marcel Teichert,Barbara Jeker,Nicolaus Kroeger,Bastian Tresckow,Carlos Larrea,Thomas Pabst
+21 authors
,Maximilian MerzJournal
Published
Nov 5, 2024
Show more
Save
Tip0
TipSave